Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies

Ruth Peters, Mattan Schuchman, Jean Peters, Michelle C Carlson, Sevil Yasar

Research output: Contribution to journalReview article

Abstract

Purpose of Review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHM) and dementia risk are less clear. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews provide comprehensive review. Our extensive review includes 24 mechanistic animal and human studies published over the last 5 years assessing relationship between AHM and cognitive function. Recent Findings: All classes of AHM showed similar result patterns in animal studies. The mechanism by which AHM exert their effect was extensively studied by evaluating well-established pathways of AD disease process, including amyloid beta (Aβ), vascular, oxidative stress and inflammation pathways, but only few studies evaluated the blood pressure lowering effect on the AD disease process. Summary: Methodological limitations of the studies prevent comprehensive conclusions prior to further work evaluating AHM in animals and larger human observational studies, and selecting those with promising results for future RCTs.

Original languageEnglish (US)
Article number66
JournalCurrent Hypertension Reports
Volume18
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Antihypertensive Agents
Dementia
Amyloid
Cognition
Observational Studies
Blood Vessels
Publications
Cognitive Dysfunction
Alzheimer Disease
Oxidative Stress
Blood Pressure
Hypertension
Inflammation

Keywords

  • Alzheimer’s disease
  • Antihypertensive medication
  • Cognitive decline
  • Dementia

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Relationship Between Antihypertensive Medications and Cognitive Impairment : Part II. Review of Physiology and Animal Studies. / Peters, Ruth; Schuchman, Mattan; Peters, Jean; Carlson, Michelle C; Yasar, Sevil.

In: Current Hypertension Reports, Vol. 18, No. 8, 66, 01.08.2016.

Research output: Contribution to journalReview article

@article{5bcbd8f808a44e2e88799ac968a191a9,
title = "Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies",
abstract = "Purpose of Review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHM) and dementia risk are less clear. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews provide comprehensive review. Our extensive review includes 24 mechanistic animal and human studies published over the last 5 years assessing relationship between AHM and cognitive function. Recent Findings: All classes of AHM showed similar result patterns in animal studies. The mechanism by which AHM exert their effect was extensively studied by evaluating well-established pathways of AD disease process, including amyloid beta (Aβ), vascular, oxidative stress and inflammation pathways, but only few studies evaluated the blood pressure lowering effect on the AD disease process. Summary: Methodological limitations of the studies prevent comprehensive conclusions prior to further work evaluating AHM in animals and larger human observational studies, and selecting those with promising results for future RCTs.",
keywords = "Alzheimer’s disease, Antihypertensive medication, Cognitive decline, Dementia",
author = "Ruth Peters and Mattan Schuchman and Jean Peters and Carlson, {Michelle C} and Sevil Yasar",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s11906-016-0673-2",
language = "English (US)",
volume = "18",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "8",

}

TY - JOUR

T1 - Relationship Between Antihypertensive Medications and Cognitive Impairment

T2 - Part II. Review of Physiology and Animal Studies

AU - Peters, Ruth

AU - Schuchman, Mattan

AU - Peters, Jean

AU - Carlson, Michelle C

AU - Yasar, Sevil

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Purpose of Review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHM) and dementia risk are less clear. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews provide comprehensive review. Our extensive review includes 24 mechanistic animal and human studies published over the last 5 years assessing relationship between AHM and cognitive function. Recent Findings: All classes of AHM showed similar result patterns in animal studies. The mechanism by which AHM exert their effect was extensively studied by evaluating well-established pathways of AD disease process, including amyloid beta (Aβ), vascular, oxidative stress and inflammation pathways, but only few studies evaluated the blood pressure lowering effect on the AD disease process. Summary: Methodological limitations of the studies prevent comprehensive conclusions prior to further work evaluating AHM in animals and larger human observational studies, and selecting those with promising results for future RCTs.

AB - Purpose of Review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHM) and dementia risk are less clear. An increased interest in AHM has resulted in expanding publications; however, none of the recent reviews provide comprehensive review. Our extensive review includes 24 mechanistic animal and human studies published over the last 5 years assessing relationship between AHM and cognitive function. Recent Findings: All classes of AHM showed similar result patterns in animal studies. The mechanism by which AHM exert their effect was extensively studied by evaluating well-established pathways of AD disease process, including amyloid beta (Aβ), vascular, oxidative stress and inflammation pathways, but only few studies evaluated the blood pressure lowering effect on the AD disease process. Summary: Methodological limitations of the studies prevent comprehensive conclusions prior to further work evaluating AHM in animals and larger human observational studies, and selecting those with promising results for future RCTs.

KW - Alzheimer’s disease

KW - Antihypertensive medication

KW - Cognitive decline

KW - Dementia

UR - http://www.scopus.com/inward/record.url?scp=84982803393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982803393&partnerID=8YFLogxK

U2 - 10.1007/s11906-016-0673-2

DO - 10.1007/s11906-016-0673-2

M3 - Review article

C2 - 27492369

AN - SCOPUS:84982803393

VL - 18

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 8

M1 - 66

ER -